Published in J Clin Endocrinol Metab on April 01, 1990
Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia (2005) 1.30
Tautomerism in drug discovery. J Comput Aided Mol Des (2010) 1.05
5alpha-reductase: history and clinical importance. Rev Urol (2004) 0.84
5α-reductase type 3 enzyme in benign and malignant prostate. Prostate (2013) 0.81
Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids. Biochem J (1992) 0.80
Dutasteride reduces alcohol's sedative effects in men in a human laboratory setting and reduces drinking in the natural environment. Psychopharmacology (Berl) (2014) 0.79
Long-Term Experience With 5-alpha-Reductase Inhibitors. Rev Urol (2003) 0.78
Medical treatment of benign prostatic hyperplasia. Postgrad Med J (2007) 0.75
Long-Term Experience with 5-alpha-Reductase Inhibitors. Rev Urol (2003) 0.75
Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride. PeerJ (2017) 0.75
Apoptosome activation, an important molecular instigator in 6-mercaptopurine induced Leydig cell death. Sci Rep (2015) 0.75
The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Engl J Med (1992) 7.16
Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry (2000) 4.87
Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc Natl Acad Sci U S A (1999) 4.62
The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med (1993) 4.61
Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet (1994) 4.33
Dissociable executive functions in the dynamic control of behavior: inhibition, error detection, and correction. Neuroimage (2002) 3.58
Norfloxacin disposition after sequentially increasing oral doses. Antimicrob Agents Chemother (1983) 3.53
Screening for chlamydial infections in women attending family planning clinics. West J Med (1983) 3.51
Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial. Ann Intern Med (2000) 2.82
A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med (1995) 2.65
Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjects. Clin Pharmacol Ther (2007) 2.53
Ohm's law survives to the atomic scale. Science (2012) 2.40
Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Arch Intern Med (1996) 2.32
Role of the ovary in the adrenal androgen excess of hyperandrogenic women. Fertil Steril (1998) 2.13
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther (1999) 2.10
The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day. Am J Cardiol (1997) 1.98
A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab (1991) 1.96
A midline dissociation between error-processing and response-conflict monitoring. Neuroimage (2003) 1.94
The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol (1988) 1.93
Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation (2000) 1.85
Effect of herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells. J Virol (1985) 1.77
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab (1983) 1.77
Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer. J Urol (2004) 1.73
Cocaine administration decreases functional connectivity in human primary visual and motor cortex as detected by functional MRI. Magn Reson Med (2000) 1.69
Quality of care for patients hospitalized with heart failure at academic medical centers. Am Heart J (1999) 1.65
Amygdala response to both positively and negatively valenced stimuli. Neuroreport (2001) 1.60
Increasing daily walking lowers blood pressure in postmenopausal women. Med Sci Sports Exerc (2001) 1.59
Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia. Urology (2002) 1.58
Piperacillin kinetics. Clin Pharmacol Ther (1979) 1.57
Albumin and nonprotein colloid solution use in US academic health centers. Arch Intern Med (1996) 1.56
Relationship of leisure-time physical activity and occupational activity to the prevalence of obesity. Int J Obes Relat Metab Disord (2001) 1.55
Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage (2005) 1.53
Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia. J Clin Endocrinol Metab (1992) 1.51
Durability of the reproductive axis in eumenorrheic women during 1 yr of endurance training. J Appl Physiol (1985) (1992) 1.49
First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial. Am J Trop Med Hyg (1998) 1.48
Validity of inspiratory and expiratory methods of measuring gas exchange with a computerized system. J Appl Physiol (1985) (2001) 1.47
Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial. Arch Intern Med (1994) 1.46
Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia. J Urol (1997) 1.46
Chloroplast Structure and Function Is Altered in the NCS2 Maize Mitochondrial Mutant. Plant Physiol (1991) 1.43
Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxin. Ann Intern Med (1993) 1.41
Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase. Endocrinology (1999) 1.38
Monoclonal antibodies for septic shock: in or out of the barn door? QRB Qual Rev Bull (1991) 1.38
Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Eur Heart J (2000) 1.38
Antihypertensive drug withdrawal syndrome. Drug Intell Clin Pharm (1982) 1.38
Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer. Prostate (2005) 1.38
How urgent is 'urgent' hypertension? Arch Intern Med (1989) 1.38
Practice-related functional activation changes in a working memory task. Microsc Res Tech (2000) 1.38
Selenate reduction by bacteria from a selenium-rich environment. Appl Environ Microbiol (1988) 1.35
Drug therapy. Sodium nitroprusside. N Engl J Med (1975) 1.34
Relationship between finger movement rate and functional magnetic resonance signal change in human primary motor cortex. J Cereb Blood Flow Metab (1996) 1.33
Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors. Osteoarthritis Cartilage (2002) 1.29
Effects of enalapril, a new converting enzyme inhibitor, in hypertension. Clin Pharmacol Ther (1982) 1.28
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group. Clin Cardiol (2000) 1.27
Effects of body mass index on the accuracy of an electronic pedometer. Int J Sports Med (2003) 1.26
Hormonal effects of an orally active 4-azasteroid inhibitor of 5 alpha-reductase in humans. Prostate (1989) 1.24
Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. J Clin Endocrinol Metab (1991) 1.24
Calmodulin-free skeletal-muscle troponin C prepared in the absence of urea. Biochem J (1981) 1.24
A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol (2007) 1.22
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women. J Womens Health Gend Based Med (2001) 1.22
The effect of sulfonylurea drugs on rabbit myocardial contractility, canine purkinje fiber automaticity, and adenyl cyclase activity from rabbit and human hearts. J Clin Invest (1972) 1.21
Biochemical studies of a patient with hereditary hepatorenal tyrosinemia: evidence of glutathione deficiency. Pediatr Res (1984) 1.20
Redox regulation of vascular smooth muscle cell differentiation. Circ Res (2001) 1.19
Nucleus accumbens dopamine release modulation by mesolimbic GABAA receptors-an in vivo electrochemical study. Brain Res (1998) 1.18
Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Pittsburgh Epidemiology of Diabetes Complications Study-V. Arterioscler Thromb (1991) 1.17
Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captopril. Am Heart J (1981) 1.17
Steady-state pharmacokinetics of nitrendipine in hepatic insufficiency. J Cardiovasc Pharmacol (1984) 1.17
Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo-controlled trials. Eur Urol (2000) 1.17
Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies. Neurology (1989) 1.17
Diet, plasma levels of beta-carotene and alpha-tocopherol, and risk of malignant melanoma. Am J Epidemiol (1990) 1.17
Profile of etodolac: pharmacokinetic evaluation in special populations. Clin Rheumatol (1989) 1.16
Biomarkers for smoking cessation. Clin Pharmacol Ther (2013) 1.15
Functional MRI of human Pavlovian fear conditioning: patterns of activation as a function of learning. Neuroreport (1999) 1.15
Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin. Antimicrob Agents Chemother (1992) 1.15
Studies of the oral bioavailability of alendronate. Clin Pharmacol Ther (1995) 1.14
Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia. Urology (2004) 1.13
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. World J Urol (2002) 1.13
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. Eur Urol (2000) 1.12
Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther (2002) 1.12
A parametric manipulation of central executive functioning. Cereb Cortex (2000) 1.11
Mapping of semantic, phonological, and orthographic verbal working memory in normal adults with functional magnetic resonance imaging. Neuropsychology (1999) 1.11
Sindbis and West Nile virus infections in the Witwatersrand-Pretoria region. S Afr Med J (1986) 1.11
The effect of treatment of final height in classical congenital adrenal hyperplasia (CAH). Acta Endocrinol Suppl (Copenh) (1986) 1.10
Stimulation of Na+ and K+ dependent adenosine triphosphatase by ouabain. Arch Biochem Biophys (1966) 1.09
Identification of a second promoter for the metY-nusA-infB operon of Escherichia coli. J Bacteriol (1990) 1.09
Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J Pharmacol Exp Ther (1999) 1.09
Carotenoid composition, concentrations, and relationships in various human organs. Clin Physiol Biochem (1990) 1.08
Cloning and characterization of an abundant subtype of the human calcitonin receptor. Mol Pharmacol (1994) 1.08
Relationships of occupational and non-occupational physical activity to abdominal obesity. Int J Obes (Lond) (2011) 1.07
Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med (1998) 1.07
Relationships among timolol doses, plasma concentrations and beta-adrenoceptor blocking activity. Br J Clin Pharmacol (1982) 1.06
Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat. J Clin Invest (1996) 1.06
The pharmacokinetics of enalapril in hospitalized patients with congestive heart failure. Br J Clin Pharmacol (1987) 1.05
Regional cerebral blood flow responses to variable frequency whisker stimulation: an autoradiographic analysis. Brain Res (2000) 1.05
Dopamine release in the nucleus accumbens during heroin self-administration is modulated by kappa opioid receptors: an in vivo fast-cyclic voltammetry study. J Pharmacol Exp Ther (1998) 1.04
Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity. Ann Intern Med (1984) 1.04
Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line. Prostate (2004) 1.03
Regulation of brain cyclic nucleotide phosphodiesterase by calmodulin. A quantitative analysis. J Biol Chem (1981) 1.02
Simultaneous heart rate-motion sensor technique to estimate energy expenditure. Med Sci Sports Exerc (2001) 1.02
Daily spermatozoal production, epididymal spermatozoal reserves and transit time of spermatozoa through the epididymis of the rhesus monkey. Biol Reprod (1976) 1.01